114 - EFFICACY AND SAFETY OF UPADACITINIB MAINTENANCE THERAPY IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN¿S DISEASE: RESULTS FROM A RANDOMIZED PHASE 3 U- ENDURE MAINTENANCE STUDY Julián Panés; Edward V. Loftus; Ana Lacerda; Laurent Peyrin- Biroulet; Geert D¿Haens; Remo Panaccione; Walter Reinisch; Edouard Louis; Minhu Chen; Hiroshi Nakase; Jakob Begun; Brigid S. Boland; Jianzhong Liu; Elena Dubcenco; Mohamed-Eslam F. Mohamed; Tian Feng; Jean-Frederic Colombel;

111 - EFFICACY AND SAFETY OF UPADACITINIB INDUCTION THERAPY IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN¿S DISEASE: RESULTS FROM A RANDOMIZED PHASE 3 U- EXCEL STUDY Edward V. Loftus; Jean-Frederic Colombel; Ana Paula Lacerda; Laurent Peyrin-Biroulet; Geert D¿Haens; Remo Panaccione; Walter Reinisch; Edouard Louis; Minhu Chen; Hiroshi Nakase; Susan Greenbloom; George DuVall; Yuri Sánchez González; Mohamed-Eslam F. Mohamed; Susan Rhee; Tian Feng; Elena Dubcenco; Julián Panés;

120 - CLINICAL AND ENDOSCOPIC IMPROVEMENTS WITH RISANKIZUMAB INDUCTION AND MAINTENANCE DOSING VERSUS PLACEBO ARE OBSERVED IRRESPECTIVE OF NUMBER OF PRIOR FAILED BIOLOGICS Marc Ferrante; Laurent Peyrin-Biroulet; Axel Dignass; David T. Rubin; Silvio Danese; Geert D¿Haens; Kristina Kligys; Sofie Berg; Jasmina Kalabic; Javier Zambrano; Yafei Zhang; Toshimitsu Fujii; Remo Panaccione; Ana Echarri Piudo;